Connective Tissue disease : Lupus Flashcards

1
Q

Hereditary vs autoimmune connective tissue disease

A

Hereditary from parents
Autoimmune from self

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Types of connective tissue disease:

A

Connective tissue diseases due to single-gene defects Ehlers-Danlos syndrome (EDS)
Epidermolysis bullosa (EB)
Marfan syndrome
Osteogenesis imperfecta

Connective tissue diseases characterized by inflammation of tissues(autoimmune diseases).
◦ Polymyositis
◦ Dermatomyositis
◦ Rheumatoid arthritis (RA)
◦ Scleroderma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Raynaud’s phenomenon – primary or secondary

A

• is usually triggered by cold temperatures, anxiety or stress.
• temporary spasm of blood vessels which blocks the flow of blood.
• triphasic colour change – white, blue, red (paler if dark skin)
• fingers, toes, ears, nose, lips or nipples
• symptoms
◦ pain
◦ numbness
◦ pins and needles

Insufficient blood to extremities:

Digital ulceration
Digital gangrene
Amputation

Management:
• Keep warm
• Stop smoking
• Calcium channel blockers
• Iloprost
• Sildenafil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Systemic lupus erythematosis
Onset and prevalence

A

• Prevalence that ranges from about 0.03% in Caucasians to 0.2% in Afro-Caribbeans
• 90% of affected patients are female
• Peak age at onset is between 20 and 30 years
• Fivefold increase in mortality compared to age- and gender-matched controls (cardiovascular disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

SLE pathophysiology
WILL NOT BE EXAMINED ON THIS SLIDE

A

Genetic factors -
◦ monozygotic twins,
◦ polymorphic variants at the HLA locus.
◦ inherited mutations in complement components C1q, C2 and
C4, in the immunoglobulin receptor FcγRIIIb or in the DNA
exonuclease TREX1.
◦ polymorphisms of genes that predispose to SLE, most of which
are involved in regulating immune cell function
• Autoantibody production
Usually directed against antigens present within the cell or
within the nucleus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clinical features

A

Variable

Systemic features include: ◦ fever
◦ weight loss
◦ mild lymphadenopathy ◦ fatigue
◦ arthralgia
• Continuing symptoms and flares/exacerbations
Butterfly rash

Joints
• Arthralgia seen in 90% of patients, with early morning stiffness.
• Tenosynovitis may result in tendon damage
• Synovitis is rare
• Jaccoud’s arthropathy is rare (related to chronic tenosynovitis/damage as opposed erosive disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Raynaud’s phenomenon

A

• Is a common symptom and may predate others symptoms
• Consider secondary Raynaud’s:
◦ age at onset of over 25 years,
◦ absence of a family history of Raynaud’s phenomenon,
◦ male patient
• Examination
capillary nail-fold loops (and oil placed on the skin) can show loss of the normal loop pattern
chronic ischaemia may lead to colour change
digital ulcers in severe disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SLE: skin

A

• Classic facial rash (up to 20% of patients)- erythematous, raised and painful or itchy over the cheeks with sparing of the nasolabial folds
• Discoid rash (hyperkeratosis and follicular plugging which can cause scarring alopecia if involves the scalp
• Diffuse, non-scarring alopecia
• Urticaria- hives
• Livedo reticularis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

SLE : renal disease (year 3)

A

• hallmark of severe disease
• regular urinalysis and blood pressure is essential
• proliferative glomerulonephritis
• presents with heavy haematuria, proteinuria and casts on urine microscopy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

SLE: Cardiovascular disease (yr2)

A

• Heart: Pericarditis, myocarditis and Libman–Sacks endocarditis (sterile vegetations)
• Arteries: Atherosclerosis is greatly increased causing a higher risk of stroke and myocardial infarction, due to:
◦ effects of inflammatory disease on the endothelium
◦ long term steroid therapy
◦ antiphospholipid antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

SLE: Lung involvement (yr2)

A

• Pleuritic pain (serositis) or pleural effusion
• Less common:
◦ pneumonitis, atelectasis, reduced lung volume and pulmonary fibrosis that leads to breathlessness
• Increased risk of thromboembolism (DVT,PE) is increased, especially if antiphospholipid antibodies present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SLE: neurological involvement & gastrointestinal involvement

A

Headache and poor concentration are common
Less commonly: sterile meningitis

Mouth ulcers are common
Peritoneal serositis can cause acute pain
Mesenteric vasculitis is serious (abdominal pain, bowel infarction or perforation)
Hepatitis is rare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SLE: Haematological abnormalities (yr2)

A

• Antibody-mediated destruction of peripheral blood cells may cause:
◦ Neutropenia
◦ Lymphopenia
◦ Thrombocytopenia
◦ Haemolytic anaemia
The degree of lymphopenia is an indictor of disease activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SLE: APLS – anti phospholipid syndrome
(Year 2)

A

• Vascular thrombosis
• Pregnancy loss
◦ Early or late
Lab criteria:
Lupus anticoagulant Anticardiolipin antibodies
on 2 occasions 3 months apart

Caused by SLE antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

SLE in pregnancy and Infants (yr4)

A

• Pregnancy loss – 13.1% total
◦ First – 6.0%, later 7.1%
• Preterm birth – 40.5%

Antibodies cross the placenta :
Pericardial effusion and conduction defects
Skin rash

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Diagnosing lupus

A

• Complex – diagnosis vs classification
• 2019: joint criteria developed (EULAR/ACR)
• Score of at least 10

ANTI NUCLEAR ANTIBODY POSITIVE TO HAVE LUPUS

17
Q

SLE: Management

A

Educate the patient
control symptoms
prevent organ damage
and maintain normal function

Avoid sun exposure and use sun blocks (factor 50)
Medicines

18
Q

SLE drug therapies

A

Skin and joints
◦ analgesics, NSAIDs and hydroxychloroquine.
◦ prednisolone, MMF, MTX, azathioprine
◦ belimumab (monoclonal antibody targets the β-cell growth factor BLyS)

End organ disease – agressive treatment
high-dose glucocorticoids and immunosuppressants
iv methylprednisolone (10 mg/kg IV) plus iv
cyclophosphamide for six cycles (SE: infection, haemorrhagic cystitis, infertility)
rituximab may be of benefit in some

19
Q

SLE: Maintenance therapy

A

Maintenance therapy
• Taper prednisolone ?long term low dose
• Immunosuppressant’s:
◦ Azathioprine ◦ Methotrexate ◦ MMF
• Address cardiovascular risk factors (hypertension and hyperlipidaemia) +HCQ
• Patients should be advised to stop smoking.
• Anticoagulation with warfarin if thrombosis and antiphospholipid antibody
syndrome,
• Assess risk of osteoporosis and hypovitaminosis D

20
Q

SLE SUMMARY

A

• Multi-system autoimmune disease
• Different presentations
• Tailor our treatments depending on different organ involvement
• May present to any department but symptoms are in keeping with lupus if there is NO OTHER explanation